\u767a\u520a\u6e08\u306e\u3082\u306e\u306fabstract\u307e\u305f\u306f\u672c\u6587\u306b\u30ea\u30f3\u30af\u3057\u3066\u3042\u308a\u307e\u3059\u3002
\nPublished papers are linked to PubMed<\/p>\n
<\/p>\n
Rothia mucilaginosa infection in a child with acute lymphoblastic leukemia.<\/p>\n Pediatr Blood Cancer. 2017 Jan;64(1):205-206. <\/p>\n Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan.<\/p>\n Int J Hematol. 2017 Jan;105(1):59-69.<\/p>\n Transient stimulation expands superior antitumor T cells for adoptive therapy.<\/p>\n JCI Insight. 2017 Jan 26;2(2):e89580.<\/p>\n Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.<\/p>\n PLoS One. 2017 Feb 3;12(2):e0171066. <\/p>\n A novel frameshift mutation leading to inherited type I antithrombin deficiency.<\/p>\n Blood Coagul Fibrinolysis. 2017 Mar;28(2):189-192.<\/p>\n Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia\/lymphoma, a Japanese nation-wide study.<\/p>\n Bone Marrow Transplant. 2017 Mar;52(3):484-488.<\/p>\n T-cell Receptor Signaling Activates an ITK\/NF-\u03baB\/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.<\/p>\n Clin Cancer Res. 2017 May 15;23(10):2506-2515. <\/p>\n Antiemetic Effectiveness and Cost-Saving of Aprepitant plus Granisetron Is Superior to Palonosetron in Gastrointestinal Cancer Patients Who Received Moderately Emetogenic Chemotherapy.<\/p>\n J Cancer. 2017 May 12;8(8):1371-1377.<\/p>\n HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway.<\/p>\n Nat Commun. 2017 May 10;8:15244.<\/p>\n Identification of functional and expression polymorphisms associated with risk for anti-neutrophil cytoplasmic autoantibody-associated vasculitis.<\/p>\n Arthritis Rheumatol. 2017 May;69(5):1054-1066.<\/p>\n Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.<\/p>\n Arthritis Res Ther. 2017 Sep 29;19(1):218.<\/p>\n Peripheral T-cell lymphoma cell line T8ML-1 highlights conspicuous targeting of PVRL2 by t(14;19)(q11.2;q13.3).<\/p>\n Haematologica. 2017 Sep;102(9):e356-e359.<\/p>\n Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.<\/p>\n Blood. 2017 Nov 2;130(18):1985-1994.<\/p>\n A study on the colonization of Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy smokers.<\/p>\n J Infect Chemother. 2017 Nov;23(11):752-756.<\/p>\n Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.<\/p>\n Int J Clin Pharm. 2017 Dec;39(6):1291-1297.<\/p>\n Comparison of Localized and Systemic Otitis Media With ANCA-Associated Vasculitis.<\/p>\n Otol Neurotol. 2017 Dec;38(10):e506-e510. <\/p>\n \u82f1\u6587\u539f\u8457\u8ad6\u6587\u3000Original papers \u767a\u520a\u6e08\u306e\u3082\u306e\u306fabstract\u307e\u305f\u306f\u672c\u6587\u306b\u30ea\u30f3\u30af\u3057\u3066\u3042\u308a\u307e\u3059\u3002 Published papers are linked to PubMed<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-1872","post","type-post","status-publish","format-standard","hentry","category-8"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t
\nOchi F, Tauchi H, Moritani K, Yonezawa S, Miyamoto H, Suemori K, Ishii E.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nTakenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, Kurokawa M, Arai S, Akashi K.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nKagoya Y, Nakatsugawa M, Ochi T, Cen Y, Guo T, Anczurowski M, Saso K, Butler MO, Hirano N.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nKawazoe H, Yano A, Ishida Y, Takechi K, Katayama H, Ito R, Yakushijin Y, Moriguchi T, Tanaka M, Tanaka A, Araki H.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nMori S, Yamanouchi J, Okamoto K, Hato T, Yasukawa M.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nFujiwara H, Fuji S, Wake A, Kato K, Takatsuka Y, Fukuda T, Taguchi J, Uchida N, Miyamoto T, Hidaka M, Miyazaki Y, Tomoyose T, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nWang T, Lu Y, Polk A, Chowdhury P, Zamalloa CM, Fujiwara H, Suemori K, Beyersdorf N, Hristov AC, Lim MS, Bailey NG, Wilcox RA.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nToda H, Kawazoe H, Yano A, Yamamoto Y, Watanabe Y, Yamamoto Y, Hiasa Y, Yakushijin Y, Tanaka A, Araki H.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nYamashita Y, Anczurowski M, Nakatsugawa M, Tanaka M, Kagoya Y, Sinha A, Chamoto K, Ochi T, Guo T, Saso K, Butler MO, Minden MD, Kislinger T, Hirano N.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nMerkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Carette S, Chung S, Cuthbertson D, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Hoffman GS, Khalidi N, Koening C, Langford CA, Mahr AD, McAlear C, Moreland L, Seo EP, Specks U, Spiera RF, Sreih A, St Clair EW, Stone JH, Ytterberg SR, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium. <\/a>
\n<\/a><\/p>\n
\n
\n<\/p>\n
\nIshizaki J, Takemori A, Suemori K, Matsumoto T, Akita Y, Sada KE, Yuzawa Y, Amano K, Takasaki Y, Harigai M, Arimura Y, Makino H, Yasukawa M, Takemori N, Hasegawa H; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nEhrentraut S, Nagel S, Pommerenke C, Dirks WG, Quentmeier H, Kaufmann M, Meyer C, Zaborski M, Geffers R, Fujiwara H, Drexler HG, MacLeod RAF.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nTawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nTakemoto S, Ebara M, Hasebe S, Yakushijin Y.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nKawazoe H, Sumikawa S, Nakauchi K, Yakushijin Y, Yamamoto Y, Watanabe Y, Tanaka A, Araki H.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nOkada M, Suemori K, Takagi D, Teraoka M, Yamada H, Hato N.<\/a><\/a><\/a><\/p>\n
\n
\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"